JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB193350

Anti-CD28 antibody [CB28]

Be the first to review this product! Submit a review

|

(2 Publications)

Mouse Monoclonal CD28 antibody. Suitable for Flow Cyt, ICC/IF and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Recombinant Fragment Protein within Human CD28.

View Alternative Names

CD28, T-cell-specific surface glycoprotein CD28, TP44

2 Images
Flow Cytometry - Anti-CD28 antibody [CB28] (AB193350)
  • Flow Cyt

Supplier Data

Flow Cytometry - Anti-CD28 antibody [CB28] (AB193350)

Flow Cytometric Analysis of paraformaldehyde-fixed Jurkat cells using ab193350 followed by goat anti-Mouse IgG-CF488 (Blue); Isotype control (Red).

Immunocytochemistry/ Immunofluorescence - Anti-CD28 antibody [CB28] (AB193350)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-CD28 antibody [CB28] (AB193350)

Immunofluorescent staining of Jurkat cells using ab193350 followed by goat anti-Mouse IgG conjugated to CF488 (green). Red Dot is used to label nuclei (red).

  • 578 PE

    PE Anti-CD28 antibody [CB28]

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

CB28

Isotype

IgG1

Light chain type

kappa

Carrier free

No

Reacts with

Human

Applications

Flow Cyt, ICC/IF

applications

Immunogen

Recombinant Fragment Protein within Human CD28.

P10747

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1-2 µg for 10^6 Cells", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1-2 µg/mL", "ICCIF-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification notes
ab193350 was purified from Bioreactor Concentrate by Protein A/G.
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.05% Sodium azide Constituents: PBS, 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD28 also known as T-cell-specific surface glycoprotein CD28 or TP44 plays an important role as a co-stimulatory receptor on T cells. This glycoprotein has a molecular mass of about 44 kDa and is located mainly on the cell surface of T cells. CD28 expression also occurs on thymocytes and some B cells. It forms part of the immunoglobulin superfamily featuring in significant antibody interactions. Researchers often use anti-CD28 antibodies for various immunological assays including CD28 ELISA to study its function.
Biological function summary

CD28 co-stimulates T cells after antigen presentation. It enhances T cell proliferation survival and cytokine production. CD28 functions alongside the T cell receptor (TCR) complex mediating signals that promote full T cell activation. This interaction amplifies the immune response forming an important axis of immune system communication. CD28 interacts with its ligands B7-1 (CD80) and B7-2 (CD86) found on antigen-presenting cells (APCs) illustrating its role in immune system dynamics.

Pathways

CD28 is integral to the PI3K/Akt and MAPK/ERK signaling pathways. These pathways conduct signals critical for cellular growth and survival linking CD28 to downstream transcription factors. The interaction with another protein CTLA-4 acts as a regulatory balance for CD28 signaling preventing over-activation of T cells. This balance influences immune homeostasis and tolerance providing a framework for understanding costimulatory and inhibitory signaling.

CD28's role becomes evident in autoimmune diseases and transplant rejection. Abnormal CD28 signaling links to rheumatoid arthritis where inappropriate T cell activation occurs. Similarly CD28 activity contributes to organ transplant rejection by stimulating T cell-mediated responses against transplanted tissues. CTLA-4 through regulatory feedback can modify these effects providing therapeutic target strategies for managing such disorders. Efforts to modulate CD28 activity involve developing therapeutic agents such as anti-CD28 monoclonal antibodies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Receptor that plays a role in T-cell activation, proliferation, survival and the maintenance of immune homeostasis (PubMed : 1650475, PubMed : 7568038). Functions not only as an amplifier of TCR signals but delivers unique signals that control intracellular biochemical events that alter the gene expression program of T-cells (PubMed : 24665965). Stimulation upon engagement of its cognate ligands CD80 or CD86 increases proliferation and expression of various cytokines in particular IL2 production in both CD4(+) and CD8(+) T-cell subsets (PubMed : 12196291, PubMed : 1650475, PubMed : 35397202). Mechanistically, ligation induces recruitment of protein kinase C-theta/PRKCQ and GRB2 leading to NF-kappa-B activation via both PI3K/Akt-dependent and -independent pathways (PubMed : 21964608, PubMed : 24665965, PubMed : 7568038). In conjunction with TCR/CD3 ligation and CD40L costimulation, enhances the production of IL4 and IL10 in T-cells (PubMed : 8617933).. Isoform 3. Enhances CD40L-mediated activation of NF-kappa-B and kinases MAPK8 and PAK2 in T-cells (PubMed : 15067037).
See full target information CD28

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

EBioMedicine 119:105884 PubMed40803203

2025

Tumour extracellular vesicle surface Protein-mRNA integration assay for early detection of epithelial ovarian cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Ying-Tzu Yen,Chen Zhao,Tian Gao,Jacqueline Ziqian Yang,Ning Kang,Jiahui Pu,Lei Qiu,Qixin Hu,Hyoyong Kim,Anmin Wang,Junseok Lee,Ryan Y Zhang,Na Liu,Yue Ma,You-Ren Ji,Yong Ju,Lynn L Zheng,James Lee-South,Vivian X Zuo,Audrey Qian,Aaron Kwan,Yating Zhang,Shenghua Zhang,Zhili Wang,Jing Ren,Huaichao Liu,Zihan Wang,Yang Yue,Jina Kim,Jennifer Sun,Gabriella A DiBernardo,Laura B James-Allan,Ying Chen,Weipei Zhu,Guoyun Wang,Renjun Pei,Sanaz Memarzadeh,Sungyong You,Bobbie J Rimel,Kate Lawrenson,Beth Y Karlan,Myung Shin Sim,Shaohua Lu,Jipeng Wan,Na Sun,Hsian-Rong Tseng,Yazhen Zhu

British journal of cancer 130:1599-1608 PubMed38519706

2024

Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoran Liu,Xiangming Cheng,Feng Xie,Kun Li,Yongcan Shi,Bin Shao,Xu Liang,Fengling Wan,Shidong Jia,Yue Zhang,Yiqiang Liu,Huiping Li
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com